Opioids Agonist Drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Opioids Agonist Drugs Market size is expected to grow at an annual average of 2% during 2021-2027. Opioids are usually prescribed to treat pain. The opioid class includes morphine, hydrocodone, oxycodone, heroin, codeine, morphine, fentanyl, and methadone. It is also used as a cough suppressant and to treat diarrhea. Opioids can be given as pills, liquids, intravenous injections, transdermal patches, or lozenges. Developed countries in North America and Europe are notorious for high levels of abuse of this drug.

The following segmentation are covered in this report:

By Application

• Pain Management
• Cough Treatment
• Diarrhea Treatment

By Type

• Codeine
• Fentanyl
• Meperidine
• Methadone
• Morphine
• Hydrocodone

Company Profile

• Purdue Pharma
• Titan pharmaceuticals
• Boehringer Ingelheim
• Janssen Pharmaceuticals, Inc
• Sanofi
• Sun Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Egalet Corporation
• Endo Pharmaceuticals Inc.
• Allergan, Plc
• Pfizer Inc

Scope of the report

The research study analyses the Opioids Agonist Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Opioids Agonist Drugs Market Report

• What was the Opioids Agonist Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Opioids Agonist Drugs Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.